New Paracox vaccine programmes offer valuable move from anti-coccidials

Schering-Plough Animal Health UK unveiled commercial trial data at this year's Poultry Fair supporting the move to Paracox 5 vaccine programmes for UK broiler producers. The company highlighted two key programmes designed specifically to offer coccidiosis protection and maintain economic production in broiler units.

Option 1 offers a complete switch from anti-coccidials. The company believes that this presents a major opportunity for producing anti-biotic free birds as well as significantly reducing the negative impact on performance of resistance to anti-coccidials. Trials with an independent broiler grower have shown, on average, birds reaching target weights sooner.

Option 2 known as 'Revitalisation' introduces Paracox 5 as an integral element of a shuttle programme. Benefits highlighted include the availability of some antibiotic free birds, improved performance in the post break crop and reduced resistance by restoring a sensitive population of oocysts. Trial data with a commercial broiler grower confirms improved FCR in post-vaccinated crops.

National Sales Manger Iain Brown is enthusiastic about the potential of the two programmes; "We believe that each option offers significant benefits to broiler producers. They meet the needs of a progressive production system that demands improved health and welfare, optimum growth and overall efficiency. Add to this an end product with premium potential," he says.